Legal & General Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $7.07K | Hold |
|
|||||
|
2024
Q4 | $7.86K | Hold |
|
|||||
|
2024
Q3 | $14.2K | Hold |
|
|||||
|
2024
Q2 | $15.6K | Hold |
|
|||||
|
2024
Q1 | $23.2K | Hold |
|
|||||
|
2023
Q4 | $17.1K | Hold |
|
|||||
|
2023
Q3 | $18.5K | Hold |
|
|||||
|
2023
Q2 | $22.1K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $15K | Hold |
|
|||||
|
2021
Q4 | $24K | Hold |
|
|||||
|
2021
Q3 | $24K | Hold |
|
|||||
|
2021
Q2 | $28K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $11K | Sell |
|
|||||
|
2019
Q4 | $19K | Hold |
|
|||||
|
2019
Q3 | $21K | Hold |
|
|||||
|
2019
Q2 | $23K | Hold |
|
|||||
|
2019
Q1 | $28K | Buy |
|
|||||
|
2018
Q4 | $11K | Sell |
|
|||||
|
2018
Q3 | $28K | Sell |
|
|||||
|
2018
Q2 | $31K | Buy |
|
|||||
|
2018
Q1 | $40K | Sell |
|
|||||
|
2017
Q4 | $48K | Hold |
|
|||||
|
2017
Q3 | $63K | Buy |
|
|||||
|
2017
Q2 | $54K | Hold |
|
|||||
|
2017
Q1 | $59K | Sell |
|
|||||
|
2016
Q4 | $65K | Buy |
|
|||||
|
2016
Q3 | $43K | Hold |
|
|||||
|
2016
Q2 | $30K | Buy |
|